The Saccharomyces cerevisiae prp mutants (prp2 through prpll) are known to be defective in pre-mRNA splicing at nonpermissive temperatures. We have sequenced the PRP4 gene and shown that it encodes a 52-kilodalton protein. We obtained PRP4 protein-specific antibodies and found that they inhibited in vitro pre-mRNA splicing, which confirms the essential role of PRP4 in splicing. Moreover, we found that PRP4 is required early in the spliceosome assembly pathway. Immunoprecipitation experiments with anti-PRP4 antibodies were used to demonstrate that PRP4 is a protein of the U4/U6 small nuclear ribonucleoprotein particle (snRNP). Furthermore, the U5 snRNP could be immunoprecipitated through snRNP-snRNP interactions in the large U4/U5/U6 complex.
The Saccharomyces cerevisiae prp mutants (prp2 through prpll) are known to be defective in pre-mRNA splicing at nonpermissive temperatures. We have sequenced the PRP4 gene and shown that it encodes a 52-kilodalton protein. We obtained PRP4 protein-specific antibodies and found that they inhibited in vitro pre-mRNA splicing, which confirms the essential role of PRP4 in splicing. Moreover, we found that PRP4 is required early in the spliceosome assembly pathway. Immunoprecipitation experiments with anti-PRP4 antibodies were used to demonstrate that PRP4 is a protein of the U4/U6 small nuclear ribonucleoprotein particle (snRNP). Furthermore, the U5 snRNP could be immunoprecipitated through snRNP-snRNP interactions in the large U4/U5/U6 complex.
In eucaryotes, nuclear pre-mRNA splicing requires a number of factors, including small nuclear RNA molecules (snRNAs) associated in protein complexes known as small nuclear ribonucleoprotein particles (snRNPs) (reviewed in 32 and 41). The snRNPs assemble onto the pre-mRNA substrate to form a large splicing complex known as spliceosome (6, 16, 17) . Five major snRNAs have been found to be essential for mRNA splicing (reviewed in reference 17a). The snRNPs containing Ul, U2, and U5 snRNAs consist of the single snRNA complexed with several specific proteins (reviewed in reference 30). In contrast, the U4 and U6 snRNAs are found base paired together in the same snRNP (4, 20) . With the exception of U6, the snRNAs possess a trimethylguanosine (m3G)-modified nucleotide cap at the 5' end (5) . Some of the snRNPs interact directly with the precursor (9, 45) . The Ul snRNP binds to the 5' splice site, the U2 snRNP binds to the branchpoint, and the U5 snRNP possibly recognizes the 3' splice site. Binding of Ul and U2 snRNPs to the pre-mRNA is required in early steps of spliceosome formation. In a later step, the U4/U6 snRNP is required for splicing; however, no association with the pre-mRNA at a specific site has been identified, and the role of the U4/U6 complex is still unknown.
Most aspects of mRNA splicing are conserved between yeast and mammalian systems. Spliceosome assembly occurs by the same general pathway, which involves splicingdependent complexes in both systems (11, 21, 38) . The snRNAs in yeast cells are larger than their mammalian counterparts, but they contain similar functional domains. In mammals, the protein components of the spliceosome include heterogeneous nuclear RNPs (12) and several snRNPs: seven core proteins common to all snRNPs and some unique proteins specific to each snRNP (reviewed in reference 30). However, specific functions have not been determined for any of them, nor have all of the proteins involved in splicing been identified. In yeast cells, pre-mRNA splicing also requires multiple protein factors, but less is known about these factors. Identification of several proteins required in yeast pre-mRNA splicing has been possible through the study of the yeast rna mutants (rna2 to rnall), which were first identified by Hartwell and are known to be defective in mRNA splicing at nonpermissive temperatures (19) . These * Corresponding author.
mutants are now called pre-mRNA-processing (prp) mutants by researchers in the field. The protein products of several of the PRP genes have been shown to be directly involved in the yeast mRNA-splicing process: antibodies directed against PRP8 immunoprecipitate specific snRNAs (29) , PRP11 is found to be associated with the spliceosome (10) , and PRP2 appears to be an extrinsic spliceosome factor required at a late stage of spliceosome formation (27) . As yet, however, no specific function has been described for any protein involved in splicing. We have examined the role of one of the PRP gene products, the PRP4 protein, in mRNA splicing and its relationship with the other components of the spliceosome. The PRP4 gene has been previously cloned by genetic complementation, and a 1.6-kilobase transcript of low abundance has been identified (44) . In this paper, we demonstrate that the PRP4 gene encodes a 52-kilodalton (kDa) protein that is essential for in vitro mRNA splicing and is required early in the spliceosome pathway. By using anti-PRP4 antibodies, we show that the large U4/US/U6 snRNP complex can be immunoprecipitated. We provide evidence that PRP4 is strongly associated with the U4/U6 snRNP.
MATERIALS AND METHODS
Strains. Escherichia coli JM101 [A(lac-pro) thi supE (F' traD36 proA+B+, lacP lacZ.AM15)] was used for cloning and amplification of plasmid DNAs, and strain AR58 (34) was used for expression of PRP4. The Saccharomyces cerevisiae strains DBY689 (a leu2.3,2-112 ura3-50 canl-101) and B364B (ot adel ade2 lys2 tyri his7 ural gall) were used for preparation of splicing extracts.
mRNA-splicing assay. mRNA-splicing extracts were prepared as described by Lustig et al. (31) . Actin precursor was synthesized in vitro by using SP6 polymerase as described by Lin et al. (28) . Splicing reactions were carried out in a buffer containing 60 mM KPO4 (pH 7), 3 mM MgCl2, 1 mM spermidine, 2 mM ATP, 3% polyethylene glycol (PEG), 0.4 nM transcript, and 40% splicing extract, as previously described by Newman et al. (35) .
Sequencing and sequence analysis. (37) . Protein (100 p.g) was injected subcutaneously into a young New Zealand White rabbit. Boosts of the same amount of material were injected after 1 month and every 2 weeks for an additional month. The antibodies obtained were used in immunoblot analysis to detect PRP4 in yeast extract or in crude lysate prepared from the PRP4-overproducing E. coli strain. The procedure of electroblotting proteins onto nitrocellulose filters and visualizing with rabbit antibody and goat anti-rabbit antibody coupled to horseradish peroxidase has been described previously (14, 48) .
Antibody inhibition of mRNA splicing in vitro. Antibody inhibition of mRNA splicing in vitro was done as described by Chang et al. (10) (11). Immunoprecipitation. Anti-m3G antibody was a generous gift from R. Luhrmann (Max-Planck Institut, Berlin, Federal Republic of Germany). RNAs were immunoprecipitated as described by Cheng and Abelson (11) and Lossky et al. (29) . Antiserum or preimmune serum was coupled to protein A-Sepharose by incubating 3 p.l of serum with 2.5 mg of protein A-Sepharose (Pharmacia, Inc.) at 4°C for 1 h in 0.5 ml of NET-2 buffer (50 mM Tris hydrochloride [pH 7.4], 0.05% Nonidet P-40, 150 mM NaCI). The resin was then washed three times with 1 ml of the same buffer or with NET buffers of different salt molarities (between 0 and 750 mM NaCI). Before immunoprecipitation, yeast extract (4 p.l) was preincubated without substrate under splicing conditions for 20 min at 23°C in a total volume of 10 p.1. In some experiments, heparin (2 ,ug/p.l of extract) was added to splicing buffer before incubation. This material was then added to the antibody-bound protein A-Sepharose and incubated for 2 h at 4°C with mixing. The resin was washed extensively with the NET buffer used previously and phenol-chloroform extracted, and the isolated RNAs were analyzed as de- TAGTGGTATC TGAAATATAT ATATACACAG TTTCTTAAAT TGTTGTCTTT ACTACTGGTA TTACTATCGC  -141 TATTACAAGC GAAGTCATTA AGTACGGAAA TGTTTAAACG TAGAGAGCTA GTAAAGGAAA GGCTGTTACA  -71  TGATCACTAA TCGTAACTTT GCAACGAGCC TGAGGGAAAT GACTAGTACT ATTACCTTGT TGAACGGAAT   1  ATG AGT AAA TAT ATT GCA CTT GAA AAT CTT CCG GTA GAT TTG CAA CAT AAA GGA GCT 
841 GGT AGT GCC TCT CAT GAT ATG ACT TGG AGA CTT TGG GAT GCG TCA ACA CAT CAA GAA CTG vector PAR3039/1 under the control of the strong T7 transcription-translation signals through the series of manipulations shown in Fig. 2 (46, 47) . The expression system used consisted of the two compatible plasmids PAR3039/1 and pGP1-2, described in Materials and Methods. When supplied with the T7 polymerase in trans, PAR3039/1-PRP4 was found to direct the synthesis of a large amount of PRP4, observed as a strong band of 52 kDa on SDS-polyacrylamide gels (Fig. 3A) . In the absence of pGP1-2, or with a truncated PRP4 gene (not shown), this 52-kDa band was not present. When cultures of E. coli(PAR3039/1-PRP4)(pGP1-2) were not induced, a low amount of PRP4 was detected, presumably as a result of synthesis of a small amount of T7 RNA polymerase.
There was a high level of expression of PRP4 in this construct; PRP4 constituted 5 to 10% of the total cellular protein in an induced culture. Like many proteins overproduced in E. coli, PRP4 was insoluble in the absence of detergent. We took advantage of this property during purification by reextracting the cell pellet with 0.5% SDS; this provided a useful step in the purification scheme for this protein. Figure 3B shows the immunoblot analysis of a crude extract prepared from the overproducing strain. A very In absence of pGP1-2, no protein was detected (lane 1). Moreover, no band corresponding to this molecular weight could be detected by the preimmune serum used at the same dilution; only a few faint bands corresponding to nonspecific cross-reacting species of low molecular weight could be found (not shown).
Immunoblot analysis of yeast extracts. The anti-PRP4 antibodies appeared to react specifically with a single protein of the yeast splicing extract (Fig. 3B, lane 4) . The intensity of the band observed on the immunoblot increased when the experiment was done with a strain transformed with a multicopy plasmid carrying the PRP4 gene (lane 5). At antibody concentrations higher than the 1:2,500 dilution shown, some cross-reacting species of lower molecular weight appeared. The anti-PRP4 antibodies, however, were clearly specific for yeast PRP4. (4 ,ul) was preincubated at 23°C for 20 min under splicing conditions in the absence of ATP (lanes 2 and 4) or in the presence of 2 mM ATP (lanes 3, 5, and 6) and then subjected to immunoprecipitation with preimmune serum (lanes 2 and 3) anti-PRP4 antibodies (lanes 4 and 5), or anti-m3G antibodies (lane 6). Incubation of the extract with antibodies and subsequent washes were done in 150 mM salt. RNAs were recovered from immune complexes, analyzed by electrophoresis on a 6% acrylamide-7 M urea gel, and probed with labeled snRNA probes as described in Materials and Methods. Lane 1 shows total RNAs from 0.5 ,u of crude splicing extract. the trimethylguanosine cap structure at their 5' ends. U6 has no cap structure, but it can be immunoprecipitated because of its association with U4 (42) . The snRNA species precipitated by the anti-PRP4 antibodies or by the anti-m3G antibodies were in the same relative proportions as observed in the total snRNAs found in the splicing extract. However, the amount of snRNAs immunoprecipitable by anti-PRP4 antibody represented only 10 to 15% of the total snRNAs.
Other snRNAs coprecipitate with PRP4 at low ionic strengths. Since snRNAs coprecipitated with PRP4, it was interesting to analyze which snRNAs were immunoprecipitated under less stringent conditions. Surprisingly, in the absence of salt, all of the snRNAs precipitated with PRP4 (data not shown); Ul and U2 were particularly abundant under these conditions. The amount of Ul and U2 precipitated decreased progressively when the salt concentration was raised to 85 mM (data not shown).
To determine whether these results reflected specific interactions between PRP4 and the snRNAs, all of the RNAs recovered from the immunoprecipitates were 3' end labeled and then analyzed by urea-gel electrophoresis. A marked increase in the amount of RNA contaminants, as well as other snRNAs immunoprecipitated with anti-m3G or anti-PRP4 antibodies, was observed at lower ionic strengths. When the immunoprecipitation was done at 50 mM NaCl or in the absence of salt, Ul, U2, U4, and U5 were immunoprecipitated along with some other snRNAs and 5S, 5.8S, and large rRNAs (Fig. 6) . When the stringency of the immunoprecipitation conditions was raised, the contaminants in the immunoprecipitation decreased, as did the amount of Ul and U2 precipitated. Only U4 and U5 were visible after immunoprecipitation with anti-PRP4 antibodies at 150 mM NaCl; the other snRNAs were no longer immu- 6 . Coprecipitation of the Ul, U2, U5, and U4/U6 snRNPs with PRP4 in low salt. After preincubation in the absence or presence of 2 mM ATP as indicated, splicing extracts were subjected to immunoprecipitation with preimmune serum (lanes 1 and 5), anti-m3G antibodies (lanes 2, 6, and 8), or anti-PRP4 antibodies (lanes 3, 4, 7, 9, and 10) under different salt conditions (0, 50, or 150 mM NaCl). The RNAs recovered from the immune complexes were labeled in a standard 3'-end-labeling reaction. The two first lanes show the in vitro transcripts of the yeast Ul, U2, U4, and U5 (long form) snRNAs.
noprecipitated. Because U6 is a poor substrate for the 3'-end-labeling reaction, it cannot be detected by this method. No detectable snRNAs were immunoprecipitated with the preimmune serum. In summary, we showed that the PRP4 protein could be coprecipitated with the five snRNAs under low ionic strength conditions; RNA contaminants were also precipitated but to a lesser extent.
PRP4 is strongly associated with U4/U6 snRNP. By raising the stringency of the immunoprecipitation conditions, we wanted to determine whether PRP4 was associated more specifically and more tightly with one particular snRNP. Precipitation of U4, U5, and U6 was stable to salt concentrations up to 250 mM but was destabilized at higher concentrations: when the salt concentration was raised to 500 mM or even 750 mM, only U4 and U6 snRNAs were immunoprecipitated (Fig. 7A) . PRP4 is therefore strongly associated with the U4/U6 snRNP. At high cation concentrations, immunoprecipitation was highly dependent on the presence or absence of ATP during the preincubation. At 750 mM NaCl, U4 and U6 snRNAs could be detected only when yeast extract was preincubated in the absence of ATP in the splicing buffer. However, the same relative amounts of U4 and U6 snRNAs were found in the immune complexes, independently of the salt or the presence or the absence of ATP.
To confirm that PRP4 is a component of the U4/U6 snRNP, we performed the immunoprecipitation after treating the extract with heparin (2 ,ug/,lI of extract) as described in Materials and Methods. Heparin has previously been used to eliminate nonspecific binding of proteins to RNAs (21) . Figure 7B shows the results of the immunoprecipitations done under different salt conditions. U2 was released first, which indicated that the association of U2 with PRP4 was very sensitive to heparin. Then Ul was released from the complex, followed by U5. It is interesting that the two forms of U5 were released at the same time. U4 and U6 were the last snRNAs to be released from the complex. Therefore, PRP4 is tightly associated with the U4/U6 snRNAs.
PRP4 is required early in the splicing pathway. Yeast actin pre-mRNA splicing studies (11, 38) have shown that at least four kinetically related complexes can be resolved by electrophoresis on native polyacrylamide gels. It has been shown that the earliest detectable complex (complex B [11] ) contains only the U2 snRNP; then the U4, U5, and U6 snRNPs joint the complex. (The Ul snRNP could not be detected by the nondenaturing gel analysis [39] ). When anti-PRP4 antibodies were added to a splicing reaction before separation of the splicing reaction mixtures on nondenaturing polyacrylamide gels, only complex B accumulated after 10 min of incubation (Fig. 8) . The PRP4 gene product and the U5 and U4/U6 snRNPs were required for further assembly of the spliceosome. The preimmune serum had no effect on spliceosome assembly; complexes B, Al, and A2 were all observed, in accordance with the assembly pathway proposed by Cheng and Abelson (11 (2 ,ul) Konarska and Sharp (23) . Splicing complex containing intermediates, products, and pre-mRNA could not be immunoprecipitated by the anti-PRP4 antibodies under normal salt conditions but only under low-salt conditions (data not shown). The simplest interpretation of this result is that the anti-PRP4 antibodies were able to precipitate the U41U5/U6 complex before it became associated with the pre-mRNA; once this particle became associated with the U2-pre-mRNA complex, the antigenic sites of PRP4 become inaccessible to the antibodies. At low salt concentrations, the conformation of the large complex may be different and the antigenic sites more accessible.
Our results showed that the U41U5/U6 complex was precipitated by anti-PRP4 antibodies both in the presence and in the absence of ATP. Previously, Lossky et al. (29) observed that this complex could be precipitated by anti-PRP8 antibodies only after preincubation with ATP. We are currently investigating this discrepancy. It could be due to differing procedures or to differences in the ATP level in extracts or in the endogenous level of the U4/U5/U6 complex. Cheng and Abelson (11) previously observed that the U41U5/U6 complex, as detected on nondenaturing gels, is dissociated by ATP. The results presented here suggest that this dissociation may be a heparin-ATP effect. Treatment of extracts with heparin (at the concentration used in the nondenaturing gel separation) and ATP (2 mM) resulted only in the anti-PRP4 precipitation of U4 and U6 (Fig. 7B) . By inducing conformational changes in the snRNPs (2, 3, 24) , ATP may make the complex sensitive to dissociation by heparin.
Results of the antibody inhibition experiment confirmed those previously obtained (31) and suggest that PRP4 is essential for mRNA splicing. As was found with the antim3G antibodies (10), the anti-PRP4 antibodies completely abolished the splicing reaction. Both steps of splicing were inhibited, indicating that the antibodies blocked the reaction before cleavage at the 3' end of the upstream exon and the formation of the intron lariat. Four splicing complexes that Antibod, A A VOL. 9, 1989 form sequentially during the course of the reaction have been described (11) . Complex B, containing predominantly pre-mRNA bound to U2 snRNP, is the first detectable intermediate. Formation of the later complexes requires the association of U5 and U4/U6 snRNPs with the pre-mRNA. Removal of the snRNPs associated with PRP4 by the antibodies inhibits the formation of these complexes and results in the accumulation of complex B. This indicates that PRP4 is involved early in the spliceosome formation and is consistent with the current models for spliceosome assembly. This result also argues against the possibility that PRP4 is present in the Ul and U2 snRNPs.
In mammalian cells, no protein unique to the U4/U6 particle has yet been identified. PRP4 is the first protein described that is specific to the yeast U4/U6 snRNP. Another snRNP protein, called PRP8, that is found to be specific for the U5 snRNP has been described by Lossky et al. (29) . It is interesting that the anti-PRP8 antibodies were also able to immunoprecipitate the U41U5/U6 particle under some conditions. Up to now, PRP4 and PRP8 were the only snRNP proteins found to be involved in yeast mRNA splicing. The antibodies now make it possible to investigate the protein composition of the U4/U6 snRNP in yeast cells. It is interesting that extra copies of PRP3 (26) are able to relieve the lethality of prp4 at restrictive temperatures, suggesting that PRP4 and PRP3 may interact in the same snRNP and may have related functions. No specific binding site for the U4/U6 particle in the splicing complex has been yet identified, and its role is still unknown. The high degree of evolutionary sequence conservation in U6 snRNA (7) suggests that the U4/U6 snRNP may have a central position in the splicing complex and may be in close contact with a number of components of the spliceosome (8) . Moreover, there are several domains highly conserved in these two snRNAs which can constitute a recognition site for binding proteins. It will be interesting to determine whether PRP4 binds specifically to U4 or U6 and to investigate the role of PRP4 in yeast pre-mRNA splicing.
